North Star Investment Management Corp. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 316 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.3%.

Quarter-by-quarter ownership
North Star Investment Management Corp. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2021$4,0000.0%2560.0%0.00%
Q2 2021$4,000
-20.0%
2560.0%0.00%
Q1 2021$5,0000.0%2560.0%0.00%
-100.0%
Q4 2020$5,000
-50.0%
256
-53.7%
0.00%0.0%
Q3 2020$10,0000.0%5530.0%0.00%0.0%
Q2 2020$10,000
+25.0%
5530.0%0.00%0.0%
Q1 2020$8,000
-27.3%
5530.0%0.00%0.0%
Q4 2019$11,000
-15.4%
553
-26.7%
0.00%0.0%
Q3 2019$13,000
-23.5%
754
-8.5%
0.00%
-50.0%
Q1 2019$17,0008240.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2019
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders